Abstract
Pharmacovigilance plays a pivotal role in ensuring the safety and efficacy of pharmaceutical products throughout their lifecycle. Monitoring and reporting adverse drug reactions (ADRs) are fundamental components of pharmacovigilance, aimed at identifying and minimizing risks associated with medication use. This paper provides an overview of the pharmacovigilance process, emphasizing the importance of robust ADR monitoring and reporting systems. It explores the various methods employed in pharmacovigilance, including spontaneous reporting, literature review, observational studies, and signal detection techniques. Additionally, the paper discusses the challenges and opportunities in ADR monitoring, such as underreporting, signal refinement, and the emergence of new data sources like social media and electronic health records. Strategies to enhance ADR reporting, including education and training initiatives for healthcare professionals and patients, as well as the utilization of advanced technology and data analytics, are also examined. Furthermore, the role of regulatory agencies, pharmaceutical companies, healthcare providers, and consumers in promoting pharmacovigilance efforts is highlighted.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
